TNF and rheumatoid arthritis: Our previous studies have shown that methotrexate (MTX) treatment for RA patients significantly decreased the gene expression of the proinflammatory cytokine tumor necrosis factor (TNF) α to a level found in healthy controls after 24 months of follow-up [26].